![Toni Weinschenk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Toni Weinschenk
Corporate Officer/Principal presso
IMMATICS N.V.
Patrimonio netto: - $ in data 31/07/2026
Profilo
Toni Weinschenk is the founder of Immatics Biotechnologies GmbH, founded in 2000, holding the title of Chief Innovation Officer since 2020.
Dr. Weinschenk is the founder of Immatics US, Inc., founded in 2015, holding the title of Chief Technology Officer since 2015.
Dr. Weinschenk currently holds the position of Chief Innovation Officer at Immatics NV since 2020.
Dr. Weinschenk earned a doctorate from Eberhard Karls Universität Tübingen.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Toni Weinschenk
| Società | Posizione | Inizio |
|---|---|---|
| IMMATICS N.V. | Corporate Officer/Principal | 01/01/2020 |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Fondatore | 01/01/2000 |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Fondatore | 01/06/2015 |
Formazione di Toni Weinschenk
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
48
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
